myCaribou’s panel discussion features experts with decades of experience completing mergers and acquisitions for medtech manufacturers and distributors. The panel explores how the current economic environment is affecting deals in the industry, including acquisition timelines, processes, and valuation models. The panelists also shared how they expect mergers and acquisitions to play a role in the future of the industry.
Whether you’re a manufacturer, distributor, or simply interested in the medtech industry, this panel discussion is a valuable opportunity to gain unique insights from industry leaders.
- The current economic environment and effects on M&A activity.
- Trends in current transactions.
- Typical process and timelines for acquisitions.
- Valuation process and timelines for acquisitions
- The role of advisors.
- How to prepare to buy or sell a business.
Mr. Hepberger is a Managing Director in Houlihan Lokey’s Healthcare Group. He has more than 15 years of industry experience, particularly in medical technology, healthcare distribution, outsourcing, and consumer health. During his career, Mr. Hepberger has advised on more than 50 M&A transactions across Benelux, DACH, the UK, Scandinavia, Spain, and Israel. He is based in the firm’s London office.
Simmons & Simmons
David is head of the Corporate and M&A Team in Simmons & Simmons Dublin. He advises on a wide range of corporate matters with his experience including foreign direct investment, M&A, private equity transactions, joint ventures, venture capital investments, and corporate reorganizations. David has expertise in the healthcare and life sciences sector including advising on some of the largest and most high-profile corporate transactions in Ireland for a diverse range of US and European clients.
VP Corporate Development
Brett has led Corporate Development, focused on M&A, within Diploma PLC’s global life sciences sector for three and a half years. He formerly ran one of Diploma’s Canadian businesses, focused on value-added distribution in the endoscopy and minimally invasive surgical space. For almost 20 years, Brett has worked with a range of technology leaders in clinically specialized segments and is experienced with all phases of product commercialization across various geographical markets, including Europe, North America, and Australasia. .